Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Clinical features and treatment outcomes of isolated secondary central nervous system lymphomas in Miyazaki Prefecture.

Kawano N, Ochiai H, Yoshida S, Yamashita K, Shide K, Shimoda H, Hidaka T, Kubuki Y, Katayose K, Toyama T, Kawano H, Matsuoka H, Ishizaki J, Maeda K, Satou S, Yano T, Yamaguchi K, Takenaka K, Shimao Y, Oshima K, Ueda A, Shimoda K.

Int J Clin Oncol. 2012 Aug;17(4):336-40. doi: 10.1007/s10147-011-0292-5. Epub 2011 Sep 10.

PMID:
21904968
2.

Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma.

Kim SJ, Oh SY, Kim JS, Kim H, Lee GW, Won JH, Shin HJ, Yang DH, Choi CW, Park J, Kim WS, Suh C.

Ann Hematol. 2011 May;90(5):539-46. doi: 10.1007/s00277-010-1104-0. Epub 2010 Oct 20.

PMID:
20960190
3.

Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.

Guirguis HR, Cheung MC, Mahrous M, Piliotis E, Berinstein N, Imrie KR, Zhang L, Buckstein R.

Br J Haematol. 2012 Oct;159(1):39-49. doi: 10.1111/j.1365-2141.2012.09247.x. Epub 2012 Jul 31. Review.

PMID:
22849793
4.

[Treatment strategy for central nervous system involvement in intravascular large B-cell lymphoma].

Shimada K.

Brain Nerve. 2011 May;63(5):467-72. Review. Japanese.

PMID:
21515926
5.

Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.

Tai WM, Chung J, Tang PL, Koo YX, Hou X, Tay KW, Quek R, Tao M, Lim ST.

Ann Hematol. 2011 Jul;90(7):809-18. doi: 10.1007/s00277-010-1150-7. Epub 2011 Jan 13.

PMID:
21229246
6.

Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse.

Villa D, Connors JM, Sehn LH, Gascoyne RD, Savage KJ.

Haematologica. 2011 Jul;96(7):1002-7. doi: 10.3324/haematol.2011.041277. Epub 2011 Apr 12.

7.

First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.

Vitolo U, Chiappella A, Ferreri AJ, Martelli M, Baldi I, Balzarotti M, Bottelli C, Conconi A, Gomez H, Lopez-Guillermo A, Martinelli G, Merli F, Novero D, Orsucci L, Pavone V, Ricardi U, Storti S, Gospodarowicz MK, Cavalli F, Sarris AH, Zucca E.

J Clin Oncol. 2011 Jul 10;29(20):2766-72. doi: 10.1200/JCO.2010.31.4187. Epub 2011 Jun 6.

8.

High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma.

Chamberlain MC, Johnston SK.

Neuro Oncol. 2010 Jul;12(7):736-44. doi: 10.1093/neuonc/noq011. Epub 2010 Feb 8.

9.

Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system (CNS).

Kawamura T, Koga S, Okamoto M, Kanno T, Iwamura H.

Radiat Med. 2001 May-Jun;19(3):145-9.

PMID:
11467381
10.
11.

Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience.

Shimazu Y, Notohara K, Ueda Y.

Int J Hematol. 2009 Jun;89(5):577-83. doi: 10.1007/s12185-009-0289-2. Epub 2009 Apr 9.

PMID:
19353238
12.

[Primary central nervous system lymphoma--a report of 32 cases with literature review].

Yi JQ, Lin TY, He YJ, Huang HQ, Xia ZJ, Xia YF, Xu RH, Guo Y, Guan ZZ.

Ai Zheng. 2006 Apr;25(4):476-80. Review. Chinese.

PMID:
16613684
13.

Central nervous system involvement in diffuse large B-cell lymphoma.

Yamamoto W, Tomita N, Watanabe R, Hattori Y, Nakajima Y, Hyo R, Hashimoto C, Motomura S, Ishigatsubo Y.

Eur J Haematol. 2010 Jul;85(1):6-10. doi: 10.1111/j.1600-0609.2010.01438.x. Epub 2010 Mar 3.

PMID:
20236301
14.

Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution.

Fukuhara S, Watanabe T, Munakata W, Mori M, Maruyama D, Kim SW, Kobayashi Y, Taniguchi H, Maeshima AM, Tanosaki R, Matsuno Y, Tobinai K.

Eur J Haematol. 2011 Nov;87(5):434-40. doi: 10.1111/j.1600-0609.2011.01679.x. Epub 2011 Aug 19.

PMID:
21740461
15.

Influence of methotrexate exposure on outcome in patients treated with MBVP chemotherapy for primary central nervous system lymphoma.

Blasco H, Senecal D, Le Gouge A, Pinard E, Benz-de Bretagne I, Colombat P, Hulot JS, Chatelut E, Le Guellec C.

Br J Clin Pharmacol. 2010 Sep;70(3):367-75. doi: 10.1111/j.1365-2125.2010.03712.x.

16.

Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis.

Patrij K, Reiser M, Wätzel L, Pels H, Kowoll A, Herrlinger U, Engert A, Linnebank M, Schackert G, Vogt-Schaden M, Egerer G, Lamprecht M, Batchelor TT, Schlegel U, Schmidt-Wolf IG; International Primary CNS Lymphoma Collaborative Group (IPCG).

Ger Med Sci. 2011;9:Doc11. doi: 10.3205/000134. Epub 2011 May 2.

17.

Secondary central nervous system lymphoma.

Tomita N, Kodama F, Kanamori H, Motomura S, Ishigatsubo Y.

Int J Hematol. 2006 Aug;84(2):128-35. Review.

PMID:
16926134
18.
19.

Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patients.

Shimada K, Murase T, Matsue K, Okamoto M, Ichikawa N, Tsukamoto N, Niitsu N, Miwa H, Asaoku H, Kosugi H, Kikuchi A, Matsumoto M, Saburi Y, Masaki Y, Yamamoto K, Yamaguchi M, Nakamura S, Naoe T, Kinoshita T; IVL Study Group in Japan.

Cancer Sci. 2010 Jun;101(6):1480-6. doi: 10.1111/j.1349-7006.2010.01555.x. Epub 2010 Mar 6.

20.

Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era.

Tomita N, Yokoyama M, Yamamoto W, Watanabe R, Shimazu Y, Masaki Y, Tsunoda S, Hashimoto C, Murayama K, Yano T, Okamoto R, Kikuchi A, Tamura K, Sato K, Sunami K, Shibayama H, Takimoto R, Ohshima R, Hatta Y, Moriuchi Y, Kinoshita T, Yamamoto M, Numata A, Ishigatsubo Y, Takeuchi K.

Cancer Sci. 2012 Feb;103(2):245-51. doi: 10.1111/j.1349-7006.2011.02139.x. Epub 2011 Nov 29.

Supplemental Content

Support Center